![]() | Feng Yong LiuDepartment of Interventional Radiology, The First Medical Center of Chinese, PLA General Hospital, 100853, Beijing, P.R. China | Department of Interventional Radiology, The ... |
KOL Resume for Feng Yong Liu
Year | |
---|---|
2021 | Department of Interventional Radiology, The First Medical Center of Chinese, PLA General Hospital, 100853, Beijing, P.R. China |
2020 | Department of Interventional Radiology, The First Medical Center, Chinese PLA General Hospital, Beijing, People’s Republic of China |
2019 | Department of Interventional Radiology, The First Medical Center of PLA General Hospital 28 Fuxing Road, Beijing 100853, China. The First Medical Center of Chinese PLA General Hospital |
2018 | Department of Interventional Radiology, Chinese People's Liberation Army General Hospital, Beijing 100853, China. Chinese PLA General Hospital, Interventional Radiology, Beijing, China;, View further author information |
2017 | Department of Interventional Radiology, Chinese PLA General Hospital, 28 Fuxing Road, 100853, Beijing, People’s Republic of China |
2016 | Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Chinese People’s Liberation Army General Hospital, Beijing, China |
2015 | Department of Interventional Radiology, the General Hospital of Chinese People’s Liberation Army, Beijing, 100853 China |
2014 | Department of Interventional Radiology, Chinese PLA General Hospital Beijing 100853, China. |
2013 | Department of Interventional Radiology, Chinese People’s Liberation Army General Hospital, 28 Fuxing Road, Beijing 100853, China |
2012 | Department of Interventional Radiology, Chinese PLA General Hospital, 28, Fuxing Rd., 100853, Beijing, China |
2010 | Department of Interventional Radiology, Clinical Division of Internal Medicine, Chinese People's Liberation Army General Hospital, Beijing 100853, China. |
2009 | Department of Interventional Radiology, General Hospital of PLA, Beijing 100853, China. |
Feng Yong Liu: Influence Statistics
Concept | World rank |
---|---|
angio cone | #1 |
sor january | #1 |
time angio | #1 |
tace large hcc | #1 |
conclusionsmiyabi angioct | #1 |
bottlenecks tace | #1 |
angioct cbctguided rfa | #1 |
local–regional tumor responses | #1 |
cbctguided rfa | #1 |
rfa sor | #1 |
sorafenib rfa sor | #1 |
tace low targeting | #1 |
rapeutic effectiveness | #1 |
dose angio | #1 |
081 rfa | #1 |
unresectable remnant | #1 |
53–177 | #1 |
effectiveness angio | #1 |
follow angio | #1 |
response angio | #1 |
rfa sor sor | #1 |
tace single tace | #1 |
curative tace | #1 |
phsensitive pda | #2 |
response mm2 | #2 |
apoptosis bibenzyls rats | #2 |
pda lipiodol | #2 |
lipidolfe2o3 | #2 |
liver orthotopic cancer | #2 |
sensitive pda | #2 |
rfa mm2 | #2 |
ca4p ptace | #2 |
pfs solitary | #2 |
tace angioct | #2 |
rats photothermal effects | #2 |
ptace laser | #2 |
original lesions sae | #2 |
lipidolfe2o3 pda | #2 |
ptace ca4p lipidolfe2o3 | #2 |
682±137 µmol | #2 |
photothermal ablation ptace | #2 |
sae rfa | #2 |
tumors treatment effectiveness | #2 |
132×10 | #2 |
ablation ptace | #2 |
values 132×10 | #2 |
strategy raml | #2 |
treated ptace | #2 |
aggressive malignancy levels | #2 |
surgery maximum diameter | #2 |
Open the FULL List in Excel | |
Prominent publications by Feng Yong Liu
BACKGROUND: Hepatocellular carcinoma (HCC) with a tumor thrombus in the inferior vena cava (IVC) and right atrium (RA) rarely occurs and is usually associated with extremely poor prognosis, we carried out this study to evaluate the efficacy and safety of a combination of trans-arterial chemoembolization (TACE) and external beam radiation therapy (EBRT) in the treatment of HCC with a tumor thrombus in the IVC and RA.
METHODS: From September 2005 to September 2008, 11 cases of HCC with a ...
Known for Tumor Thrombus | Hepatocellular Carcinoma | Vena Cava | Radiation Therapy | Ebrt Hcc |
Robot-assisted Level III-IV Inferior Vena Cava Thrombectomy: Initial Series with Step-by-step Procedures and 1-yr Outcomes
[ PUBLICATION ]
BACKGROUND: Level III-IV robot-assisted inferior vena cava (IVC) thrombectomy (RA-IVCT) has been reported in limited series.
OBJECTIVE: To report our initial series of level III-IV RA-IVCT with step-by-step procedures and 1-yr outcomes.
DESIGN, SETTING, AND PARTICIPANTS: From November 2014 to January 2018, 13 patients with level III-IV IVC tumor thrombi underwent RA-IVCT with a minimum of 1-yr follow-up.
SURGICAL PROCEDURE: Level III RA-IVCT requires liver mobilization and clamping of ...
Known for Vena Cava | Initial Series | Level Iii | Ivc Thrombectomy Ivct | Perioperative Outcomes |
BackgroundSurgical therapy for symptomatic polycystic liver disease (PLD) is effective but has substantial mortality and morbidity. Minimally invasive options such as laparoscopic fenestration, percutaneous cyst aspiration with or without injection of a sclerosing solution have had disappointing results. Because the hepatic cysts in autosomal dominant polycystic kidney disease (ADPKD) patients are mostly supplied from hepatic arteries but not from portal veins, therefore, transcatheter ...
Known for Polycystic Liver | Iodized Oil Patients | Tae Mixture | Arterial Embolization | Hepatic Artery Branches |
Robot-assisted Retrohepatic Inferior Vena Cava Thrombectomy: First or Second Porta Hepatis as an Important Boundary Landmark
[ PUBLICATION ]
BACKGROUND: Robot-assisted retrohepatic inferior vena cava (IVC) thrombectomy (RA-R-IVCTE) has been reported only for limited series.
OBJECTIVE: To describe in detail the techniques for RA-R-IVCTE with regard to the relationship of a proximal thrombus to either the first porta hepatis (FPH) or second porta hepatis (SPH).
DESIGN, SETTING, AND PARTICIPANTS: From May 2013 to July 2016, 22 patients with R-IVC tumor thrombi were admitted to our hospital.
SURGICAL PROCEDURE: RA-R-IVCTE was ...
Known for Porta Hepatis | Vena Cava | Ivc Thrombectomy | Proximal Thrombus | Selected Patients |
Hepatocellular carcinoma associated with budd-chiari syndrome: imaging features and transcatheter arterial chemoembolization
[ PUBLICATION ]
BACKGROUND: Budd-Chiari syndrome (BCS) often leads to hepatocellular carcinoma (HCC). Transcatheter arterial chemoembolization (TACE) has been increasingly used to treat BCS patients with HCC. The purposes of this study were to illustrate imaging features in BCS patients with HCC, and to analyze the effects of TACE on BCS patients with HCC.
METHODS: 246 consecutive patients with primary BCS were retrospectively studied. 14 BCS patients with HCC were included in this study. BCS were ...
Known for Hepatocellular Carcinoma | Bcs Patients | Chiari Syndrome | Arterial Chemoembolization | Imaging Features |
Comparison of Sonazoid and SonoVue in the Diagnosis of Focal Liver Lesions: A Preliminary Study
[ PUBLICATION ]
OBJECTIVE: This study aimed to compare the efficacy of Sonazoid and SonoVue in subjects with focal liver lesions.
METHODS: The patients who had untreated focal solid liver lesions confirmed by B-mode ultrasonography were eligible for the study. The target lesion and whole liver were scanned by gray scale ultrasonography; then, contrast-enhanced ultrasonography was performed, and the results were evaluated blindly. The main end point was accuracy improvement with postcontrast versus ...
Known for Focal Liver Lesions | Sonazoid Sonovue | Accuracy Improvement | Ultrasonography Contrast | Image Enhancement |
Purpose To determine if combretastatin A-4 phosphate disodium (CA4P) can enhance the tumor uptake of doxorubicin (Dox)-loaded, polyethylene glycol (PEG)-coated hollow gold nanospheres (HAuNS) mixed with ethiodized oil for improved photothermal ablation (PTA)-chemoembolization therapy (CET) of hepatocellular carcinoma (HCC) in rats. Materials and Methods Animal experiments were approved by the institutional animal care and use committee and performed from February 2014 to April 2015. Male ...
Known for Hepatocellular Carcinoma | Photothermal Ablation | Chemoembolization Therapy | Gold Nanospheres | Loaded Hollow |
AIM: Hepatocelluar carcinoma (HCC) with pulmonary metastasis is considered incurable. This study addresses the efficacy of the combination of systemic therapy using sorafenib and local treatment using transarterial chemoembolization (TACE) for intrahepatic and bronchial transarterial chemoinfusion (TAI) for pulmonary lesions for this condition.
METHODS: In all, 52 HCC patients with pulmonary metastasis were treated with sorafenib and TACE/TAI for intrahepatic and intrapulmonary lesions. ...
Known for Pulmonary Metastasis | Transarterial Chemoembolization | Hepatocellular Carcinoma | Tace Treatment | Systemic Therapy |
OBJECTIVE: This work aimed to evaluate the safety and clinical efficacy of transcatheter arterial chemoembolization (TACE) combined with c-arm cone-beam CT guided synchronous radiofrequency ablation (RFA) in treatment of large hepatocellular carcinoma (HCC).
METHODS: 21 patients with large HCC were studied from January 2010 to March 2012. TACE combined with synchronous C-arm cone-beam CT guided RFA were performed on a total of 25 lesions. Conventional imaging examination (CEUS, enhanced ...
Known for Large Hepatocellular Carcinoma | Chemoembolization Combined | Arm Cone | Radiofrequency Ablation | Transcatheter Arterial |
BACKGROUND: Currently, the treatment of large hepatocellular carcinoma (HCC) is still a challenging problem. Transcatheter arterial chemoembolization (TACE) is the main treatment for intermediate end-stage HCC, while it is only a palliative and not a curative treatment due to the existence of residual tumors, and radiofrequency ablation (RFA) has limitations in complete ablation of large HCC. We hypothesized that TACE combined with simultaneous RFA (herein referred to as TACE + RFA) ...
Known for Tace Rfa | Radiofrequency Ablation | Large Hepatocellular | Chemoembolization Combined | Transcatheter Arterial |
To analyze safety and efficacy of patterns of sorafenib and TACE therapy under real-life clinical practice conditions. A total of 338 Chinese patients with unresectable hepatocellular carcinoma (HCC) from the international database of the GIDEON non-interventional trial were included in this analysis. Endpoints were overall survival (OS), progression-free survival (PFS), time to progression (TTP) and safety. Two major patterns in the use of sorafenib observed in current Chinese clinical ...
Known for Tace Treatment | Gideon Study | Bclc Stage | Hepatocellular Chemoembolization | Antineoplastic Agents Carcinoma |
Stent-grafts placement for treatment of massive hemorrhage from ruptured hepatic artery after pancreaticoduodenectomy
[ PUBLICATION ]
AIM: To present a series of cases with life-threatening hemorrhage from ruptured hepatic artery pseudoaneurysm after pancreaticoduodenectomy (PD) treated with placement of stent-grafts.
METHODS: Massive hemorrhage from ruptured hepatic artery pseudoaneurysm after PD in 9 patients (6 men, 3 women) at the age of 23-75 years (mean 48 years), were treated with placement of percutaneous endovascular balloon-expandable coronary stent-grafts. All patients were not suitable for embolization ...
Known for Hepatic Artery | Massive Hemorrhage | Recurrent Bleeding | Stent Grafts | Ruptured Pseudoaneurysm |
Interventional treatment for symptomatic acute-subacute portal and superior mesenteric vein thrombosis
[ PUBLICATION ]
AIM: To summarize our methods and experience with interventional treatment for symptomatic acute-subacute portal vein and superior mesenteric vein thrombosis (PV-SMV) thrombosis.
METHODS: Forty-six patients (30 males, 16 females, aged 17-68 years) with symptomatic acute-subacute portal and superior mesenteric vein thrombosis were accurately diagnosed with Doppler ultrasound scans, computed tomography and magnetic resonance imaging. They were treated with interventional therapy, including ...
Known for Interventional Treatment | Vein Thrombosis | Subacute Portal | Superior Mesenteric | Intestinal Necrosis |
The purpose of this investigation was to assess the feasibility and effectiveness of transradial approach for transcatheter superior mesenteric artery (SMA) urokinase infusion therapy in patients with acute extensive portal and superior mesenteric venous thrombosis. During a period of 7 years, 16 patients with acute extensive thrombosis of the portal (PV) and superior mesenteric veins (SMV) were treated by transcatheter selective SMA urokinase infusion therapy by way of the radial ...
Known for Superior Mesenteric | Urokinase Infusion | Vein Thrombosis | Transcatheter Selective | Artery Sma |
MOF‐Derived Double‐Layer Hollow Nanoparticles with Oxygen Generation Ability for Multimodal Imaging‐Guided Sonodynamic Therapy
[ PUBLICATION ]
The high reactive oxygen species (ROS) generation ability and simple construction of sonosensitizer systems remain challenging in sonodynamic therapy against the hypoxic tumor. In this work, we rationally prepared MOF-derived double-layer hollow manganese silicate nanoparticle (DHMS) with highly effective ROS yield under ultrasound irradiation for multimodal imaging-guided sonodynamic therapy (SDT). The presence of Mn in DHMS increased ROS generation efficiency because it could be ...
Known for Sonodynamic Therapy | Multimodal Imaging | Hollow Nanoparticles | Tumor Hypoxia | Ultrasound Irradiation |
Key People For Hepatocellular Carcinoma
Feng Yong Liu:Expert Impact
Concepts for whichFeng Yong Liuhas direct influence:Hepatocellular carcinoma, Radiofrequency ablation, Tumor thrombus, Surgical resection, Large hepatocellular carcinoma, Sonodynamic therapy, Vena cava, Microwave ablation.
Feng Yong Liu:KOL impact
Concepts related to the work of other authors for whichfor which Feng Yong Liu has influence:Hepatocellular carcinoma, Portal vein, Radiofrequency ablation, Transarterial chemoembolization, Tumor thrombus, Sonodynamic therapy, Hepatic artery.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |